Form4insider filings, from the source

SEC Form 4 · accession 0001225208-15-006622

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Keith D Dawkins
Officer — EVP, Global Chief Med. Off.
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 27, 2015M4,777$0.00A175,838D
Common StockF1Feb 27, 2015M3,981$0.00A179,819D
Common StockFeb 27, 2015F4,126$16.90D175,693D
Common StockF1Feb 28, 2015M4,888$0.00A180,581D
Common StockF1Feb 28, 2015M4,736$0.00A185,317D
Common StockFeb 28, 2015F4,534$16.90D180,783D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Deferred Stock UnitsF3,F1,F2—Feb 27, 2015M3,981D——Common Stock3,98143,050D
Deferred Stock UnitsF3,F1,F4—Feb 27, 2015M4,777D——Common Stock4,77738,273D
Deferred Stock UnitsF3,F1,F5—Feb 28, 2015M4,736D——Common Stock4,73633,537D
Deferred Stock UnitsF3,F1,F6—Feb 28, 2015M4,888D——Common Stock4,88828,649D

Explanation of responses